Integrative Determinants of Chronic Kidney Disease: Psychodynamic Stress, Nutritional Dysregulation, and Environmental Toxicity as Emerging Pharmacological Targets

Even if hemodynamic and metabolic treatments for Chronic Kidney Disease (CKD) have been shown to work, there is still a significant risk of progression to End-Stage Kidney Disease. This paper asserts that the ongoing deterioration is influenced by a "integrative toxic milieu" defined by three neglected factors: psychodynamic stress, dietary dysregulation, and environmental toxicity. By combining data from important recent trials like TACT2, VALOR-CKD, and AYAME, we look at the molecular pathways that link these factors to renal fibrosis. We focus on the Psycho-Neuro-Endocrine-Immune (PNEI) and gut-kidney axes. The review also looks at how well new drugs like aldosterone synthase inhibitors, Nrf2 activators, and chelation therapies work. It makes the case for a shift in thinking toward a more comprehensive, multi-target pharmacological approach that goes beyond just the glomeruli to include the patient's overall responses to stress from their environment and their own body.